Abstract
GPR139 is an orphan G protein-coupled receptor expressed mainly in the central nervous system. We developed a pharmacophore model based on known GPR139 surrogate agonists which led us to propose aromatic-containing dipeptides as potential ligands. Upon testing, the dipeptides demonstrated agonism in the Gq pathway. Next, in testing all 20 proteinogenic l-α-amino acids, L-tryptophan and l-phenylalanine were found to have EC50 values of 220 and 320 μM, respectively, making them the first putative endogenous agonists for GPR139.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acids, Aromatic / chemistry*
-
Amino Acids, Aromatic / pharmacology*
-
Computer-Aided Design
-
Dipeptides / chemistry*
-
Dipeptides / pharmacology*
-
Drug Design*
-
HEK293 Cells
-
Humans
-
Models, Molecular
-
Nerve Tissue Proteins / agonists*
-
Nerve Tissue Proteins / metabolism
-
Phenylalanine / chemistry
-
Phenylalanine / pharmacology
-
Receptors, G-Protein-Coupled / agonists*
-
Receptors, G-Protein-Coupled / metabolism
-
Tryptophan / chemistry
-
Tryptophan / pharmacology
Substances
-
Amino Acids, Aromatic
-
Dipeptides
-
GPR139 protein, human
-
Nerve Tissue Proteins
-
Receptors, G-Protein-Coupled
-
Phenylalanine
-
Tryptophan